Osteoporosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Osteoporosis Clinical Trial Report Overview
A total of 2,254 osteoporosis clinical trials were conducted as of December 2023. The osteoporosis clinical trial report provides a comprehensive understanding of the osteoporosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · The US
· Japan · China · Canada · The UK · Australia · Denmark · Italy |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Novartis AG
· Eli Lilly and Co. · Amgen Inc · F. Hoffmann-La Roche Ltd · Takeda Pharmaceutical Co. Ltd. · Sanofi · GSK · Others |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Osteoporosis Clinical Trials Segmentation by Regions and Countries
Asia-Pacific led the Osteoporosis clinical trials landscape with more than 40% of the clinical trials conducted as of December 2023.
The key regions considered for osteoporosis clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In the country-wise analysis, the US had the highest number of osteoporosis clinical trials, as of December 2023. Denmark had the highest average patient enrollment of osteoporosis clinical trials, during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Japan had the highest proportion of Osteoporosis to Musculoskeletal Disorders clinical trials as of December 2023.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Mexico had the highest proportion of Osteoporosis to Musculoskeletal Disorders clinical trials as of December 2023.
Osteoporosis Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Osteoporosis Clinical Trials
Osteoporosis Clinical Trials Segmentation by Sponsor Types
The key sponsor types for osteoporosis clinical trials are company, institution, and the government. As of December 2023, more than 50% of osteoporosis clinical trials conducted were sponsored by institution sponsor type, followed by the company.
Osteoporosis Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy the Full Report for More Insights into the Osteoporosis Clinical Trials Sponsor Types
Osteoporosis Clinical Trials - Competitive Landscape
In 2023, Novartis AG conducted the highest number of osteoporosis clinical trials.
A few of the leading sponsors for osteoporosis clinical trials are:
- Novartis AG
- Eli Lilly and Co.
- Amgen Inc
- Hoffmann-La Roche Ltd
- Takeda Pharmaceutical Co. Ltd.
- Sanofi
- GSK
Osteoporosis Clinical Trials Analysis by Leading Companies, 2023 (%)
Buy Full Report to Know More About the Leading Players of Osteoporosis Clinical Trials
Segments Covered in the Report
Osteoporosis Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Osteoporosis Clinical Trials Country Outlook (2023)
- The US
- Japan
- China
- Canada
- The UK
- Australia
- Denmark
- Italy
Osteoporosis Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key investment strategies.
- Helps in identifying time-saving and cost-efficient locations to conduct clinical trials.
- Provides top-level analysis of the global clinical trials market to help in identifying key business opportunities.
- Helps in understanding trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Eli Lilly and Co
Amgen Inc
F. Hoffmann-La Roche Ltd
Merck & Co Inc
Takeda Pharmaceutical Co Ltd
Sanofi
GSK plc
Pfizer Inc
Radius Health Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of osteoporosis clinical trials in December 2023?
Asia-Pacific accounted for the highest number of osteoporosis clinical trials as of December 2023.
-
Which country conducted the highest number of osteoporosis clinical trials in December 2023?
The US conducted the highest number of osteoporosis clinical trials as of December 2023.
-
Which sponsor type was the most prominent in the osteoporosis clinical trials in December 2023?
As of December 2023, most of the osteoporosis clinical trials conducted were sponsored by institution sponsor type.
-
Which are the leading sponsors of osteoporosis clinical trials?
A few of the leading sponsors of osteoporosis clinical trials are Novartis AG, Eli Lilly and Co., Amgen Inc, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Co. Ltd., Sanofi, and GSK, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.